Phase Ii Study of beta-2'-deoxythioguanosine in adult acute leukemia
Omura, G.A.; Vogler, W.R.; Smalley, R.V.; Maldonado, N.; Broun, G.O.; Knospe, W.H.; Ahn, Y.S.; Faguet, G.B.
Cancer Treatment Reports 61(7): 1379-1381
1977
ISSN/ISBN: 0361-5960 PMID: 338147 Document Number: 4456
Document emailed within 1 workday

Related Documents
Omura, G.A. 1977: Combination therapy with 5-azacytidine plus beta-2'-deoxythioguanosine in adult acute leukemia Cancer Treatment Reports 61(5): 915-917Higgins, G.R.; Jamin, D.C.; Shore, N.A.; Momparler, R.; Hartman, G.; Siegel, S.E. 1985: Phase i evaluation of beta-2'-deoxythioguanosine in pediatric patients with leukemia Cancer Treatment Reports 69(6): 699-701
Yamada, K.; Suzuki, H.; Kato, Y. 1980: Phase IIi study of N4-behenoyl-l-beta-D-arabinofuranosylcytosine in adult acute leukemia-BH-AC-DMP therapy Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 43(6): 1080-1085
Kimura, K. 1987: A phase Ii study of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine (PL-AC) in patients with acute leukemia and myelodysplastic syndromes. Cooperative Study Group for PL-AC Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(8): 2475-2481
Miyawaki, S.; Mizoguchi, H.; Tomonaga, M.; Kanamaru, A.; Tsukagoshi, S.; Nakamura, T.; Ohashi, Y.; Yoshida, S.; Ohno, R. 1998: A phase Ii study with high-dose cytarabine (NS-075) in adult patients with relapsed and refractory acute leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(14): 2229-2242
Masaoka, T.; Ogawa, M.; Yamada, K.; Kimura, K.; Ohhashi, Y. 1993: A late phase Ii comparative study of idarubicin + cytarabine and daunorubicin + cytarabine in adult patients with acute non-lymphocytic leukemia. Idarubicin Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(13): 1995-2005
Abrams, R.A.; Hanson, G.; Hansen, R.M.; Anderson, T. 1986: Phase Ii study of combination chemotherapy with etoposide and amsacrine in relapsed adult leukemia Cancer Treatment Reports 70(4): 535
Martino, R.; Guardia, R.; Altés, A.; Sureda, A.; Brunet, S.; Sierra, J. 1999: Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol Haematologica 84(3): 226-230
Kantarjian, H.M.; Smith, T.; Estey, E.; Polyzos, A.; O'brien, S.; Pierce, S.; Beran, M.; Feldman, E.; Keating, M.J. 1992: Prognostic significance of elevated serum beta 2-microglobulin levels in adult acute lymphocytic leukemia American Journal of Medicine 93(6): 599-604
Gagliano, R.G.; Panettiere, F.J.; Haas, C.D.; Baker, L.; Hewlett, J.; Stuckey, W.J.; O'Bryan, R.M.; Bottomley, R.; Heilburn, L.K. 1981: Evaluation of beta-2'-deoxythioguanosine combined with methyl-CCNU or mitomycin in advanced colorectal cancer. a Southwest Oncology Group study Cancer Clinical Trials 4(4): 401-405
Asou, N.; Adachi, K.; Tamura, J.; Kanamaru, A.; Kageyama, S.; Hiraoka, A.; Omoto, E.; Akiyama, H.; Ohno, R. 2000: Treatment of acute promyelocytic leukemia with all-trans retinoic acid and chemotherapy--multicenter trial of the Japan Adult Leukemia Study Group (JALSG) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(8): 1168-1173
Marty, M.; Ferme, C.; Gisselbrecht, C.; Guy, H.; Clark, M.J.; Bancillon, A.; Boiron, M. 1985: Phase i study of bisantrene in acute nonlymphoblastic leukemia Cancer Treatment Reports 69(6): 703-705
Van Echo, D.A.; Wiernik, P.H. 1978: Phase i study of neocarzinostatin in patients with acute leukemia Cancer Treatment Reports 62(9): 1363-1365
Lerede, T.; Bassan, R.; Rossi, A.; Di Bona, E.; Rossi, G.; Pogliani, E.M.; Motta, T.; Torri, V.; Buelli, M.; Comotti, B.; Viero, P.; Rambaldi, A.; Cortelazzo, S.; Rodeghiero, F.; Barbui, T. 1996: Therapeutic impact of adult-type acute lymphoblastic leukemia regimens in B-cell/L3 acute leukemia and advanced-stage Burkitt's lymphoma Haematologica 81(5): 442-449
Taguchi, T.; Ohta, K.; Hotta, T.; Shirakawa, S.; Masaoka, T.; Kimura, I. 1997: Menogaril (TUT-7) late phase Ii study for malignant lymphoma, adult T-cell leukemia and lymphoma (ATLL) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(10): 1263-1271
Decker, R.W.; Ho, W.G.; Champlin, R.E. 1987: Phase II study of amsacrine and high-dose cytarabine for resistant acute myelogenous leukemia Cancer Treatment Reports 71(9): 881-882
Ogawa, M.; Masaoka, T.; Yamada, K.; Kimura, K. 1993: Early phase Ii study of Idarubicin, a new anthracycline anticancer drug, in acute leukemia. Idarubicin Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(7): 897-906
Kikuchi, H.; Ono, K.; Ohtsuka, E.; Tokimatsu, I.; Tashiro, T.; Nasu, M.; Sonoda, Y.; Yokoyama, S. 1994: Problems concerned with adult T-cell leukemia. 1) Causes of death and early diagnosis of cytomegalovirus pneumonia in adult T-cell leukemia. 2) Clinicopathological features of CD30 positive adult T-cell leukemia Rinsho Byori. Japanese Journal of Clinical Pathology 42(12): 1253-1260
Vats, T.S.; Lui, V.; Trueworthy, R.; van Eys, J. 1981: Phase Ii clinical trial of dianhydrogalactitol for remission induction in children with acute leukemia: a Southwest Oncology Group Study Cancer Treatment Reports 65(1-2): 121-122
Forman, S.J.; Blume, K.G. 1991: Marrow transplantation versus chemotherapy for adult patients with acute lymphoblastic leukemia: results of a clinical study Transplantation Proceedings 23(1 Part 2): 1713-1714